Alexander Kintu

机构：Gilead Sciences (United States) · ORCID：0000-0003-3957-1487

发表论文 22 篇 · 总被引 1269 次 · h-index 11

代表论文

• Twice-Yearly Lenacapavir or Daily F/TAF for HIV Prevention in Cisgender Women (2024 · New England Journal of Medicine · 被引 473)
• What's Love Got to Do With It? Explaining Adherence to Oral Antiretroviral Pre-Exposure Prophylaxis for HIV-Serodiscordant Couples (2012 · JAIDS Journal of Acquired Immune Deficiency Syndromes · 被引 254)
• Burden of non-communicable diseases from infectious causes in 2017: a modelling study (2020 · The Lancet Global Health · 被引 171)
• Long-term safety and efficacy of emtricitabine and tenofovir alafenamide vs emtricitabine and tenofovir disoproxil fumarate for HIV-1 pre-exposure prophylaxis: week 96 results from a randomised, double-blind, placebo-controlled, phase 3 trial (2021 · The Lancet HIV · 被引 91)
• Concomitant herbal medicine and Antiretroviral Therapy (ART) use among HIV patients in Western Uganda: A cross-sectional analysis of magnitude and patterns of use, associated factors and impact on ART adherence (2012 · AIDS Care · 被引 59)
• Cost‐effectiveness analysis of integrating screening and treatment of selected non‐communicable diseases into HIV/AIDS treatment in Uganda (2020 · Journal of the International AIDS Society · 被引 46)